Double immunofluorescence shows coexpression of Bcl-x with GFAP in a variety of glial lesions

Journal of Neuro-Oncology

Volumn 80, Issue 3, 2006, Pages 235-242

  Tan, Kong Bing ^a   Koh, Hui Keng Magdalene ^a,b   Tan, Soo Yong ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Apoptosis; Astrocytomas; Gliomas; Gliosis; Neuropathology

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN BCL X;

ANTIBODY LABELING; ARTICLE; ASTROCYTE; ASTROCYTOMA; BRAIN BIOPSY; BRAIN DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENCEPHALITIS; EPENDYMOMA; GLIA CELL; GLIOBLASTOMA; GLIOMA; GLIOSIS; HIPPOCAMPAL SCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; NEUROEPITHELIOMA; OLIGODENDROGLIOMA; PROTEIN EXPRESSION; SUBEPENDYMOMA;

ASTROCYTES; BCL-X PROTEIN; BRAIN NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HUMANS; MENINGITIS; NEUROGLIA;

EID: 33751213399     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9184-3     Document Type: Article

References (18)

1. L through caspase interaction. Proc Natl Acad Sci USA 95:554-559
2. Mizuguchi M, Sohma O, Takashima S et al (1996) Immunochemical and immunohistochemical localization of Bcl-x protein in the rat central nervous system. Brain Res 712:281-286
3. Krajewski S, Krajewska M, Ehrmann J et al (1997) Immunohistochemical analysis of Bcl-2, Bcl-x, Mcl-1, and Bax in tumors of central and peripheral nervous system origin. Am J Pathol 150:805-814
4. Rieger L, Weller M, Bornemann A, Schabet M, Dichgans J, Meyermann R (1998) BCL-2 family protein expression in human malignant glioma: A clinical-pathological correlative study. J Neurol Sci 155:68-75
5. Prayson RA (1999) Bcl-2 and Bcl-x expression in gangliogliomas. Hum Pathol 30:701-705
6. Szkudlarek M, Lebelt A, Klim B et al (2004) Apoptosis phenomenon in the selected neoplasms of the glial origin. Rocz Akad Med Bialymst 49 Suppl 1:16-18
7. Steinbach JP, Wolburg H, Klumpp A, Probst H, Weller M (2003) Hypoxia-induced cell death in human malignant glioma cells: Energy deprivation promotes decoupling of mitochondrial cytochrome c release from caspase processing and necrotic cell death. Cell Death Differ 10:823-832
8. Reifenberger G, Szymas J, Wechsler W (1987) Differential expression of glial- and neuronal-associated antigens in human tumors of the central and peripheral nervous system. Acta Neuropathol (Berl) 74:105-123
9. Krajewski S, Krajewska M, Shabaik A et al (1994) Immunohistochemical analysis of in vivo patterns of Bcl-x expression. Cancer Res 54:5501-5507
10. Alonso G, Guillemain I, Dumoulin A, Privat A, Patey G (1997) Immunolocalization of Bcl-xL/S in the central nervous system of neonatal and adult rats. Cell Tissue Res 288:59-68
11. Kirkin V, Joos S, Zornig M (2004) The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 1644:229-249
12. Olopade OI, Adeyanju MO, Safa AR et al (1997) Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am 3:230-237
13. Van de Putte G, Holm R, Lie AK, Baekelandt M, Kristensen GB (2005) Markers of apoptosis in stage IB squamous cervical carcinoma. J Clin Pathol 58:590-594
14. Ogura E, Senzaki H, Yamamoto D et al (1999) Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas. Oncol Rep 6:365-369
15. Sorenson CM (2004) Bcl-2 family members and disease. Biochim Biophys Acta 1644:169-177
16. Reifenberger G, Kros JM, Burger PC, Louis DN, Collins VP (2000) Oligodendroglial tumors and mixed gliomas. In: Kleihues CW (ed) Pathology and genetics: Tumors of the nervous system. Lyon, IARC Press, pp 55-69
17. Gellrich S, Ventura R, Jones M, Tan SY, Mason DY (2004) Immunofluorescent and FISH analysis of skin biopsies. Am J Dermatopathol 26:242-247
18. Mokhtari K, Paris S, Aguirre-Cruz L et al (2005) Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification. Neuropathol Appl Neurobiol 3:62-69